Achieving Successful Clinical Trial Oversight During Global Crises: Measuring the Impact Across a Sponsor's Portfolio

The impact that external events like the COVID-19 pandemic can have on clinical trials, as well as a company's entire drug development portfolio, can be far reaching. Tracking metrics associated with these crises is essential to enable study teams to follow global trends of the impact. The ability to adapt to configurations such as sponsor-specific metrics labels, thresholds for key performance indicators (KPIs) and quality tolerance limits (QTLs) are necessities to ensure successful trial oversight in an ever-changing clinical trial environment. Join this informative webinar where presenters will discuss how integrating data sources and reporting on metrics and KPIs in a thoughtful and clear way can enable study teams to quickly ascertain the health of a study or group of studies in crisis circumstances. A case study demonstrating the tracking of metrics important to COVID-19 will also be presented.